Nuclear Medicine Parathyroid Gland Studies (December 2016)

Why This Topic Matters

Parathyroid imaging evolved over time, and correct reporting depends on the service type, imaging approach, and date of service. This article helps readers identify the relevant coding framework for these studies and understand why current reporting differs from earlier practice.

Article Sections

1. December 2016 pages 9-10

   Introductory overview of parathyroid gland studies in nuclear medicine and the basic concepts used to describe imaging approaches. It also introduces the general context for coding and reporting.

2. Diagnostic Radiopharmaceuticals Used in Parathyroid Studies

   Discussion of the radiopharmaceuticals referenced for parathyroid studies and the general reporting considerations tied to supply coding and administration dates. The section presents the broader framework for documenting diagnostic agents used in these procedures.

3. Coding Tip

   General guidance about using organ-specific versus general CPT coding and about documenting unlisted procedures. It provides broad reporting context without focusing on a specific clinical pathway.

4. Current Reporting

   Summary of the current CPT reporting framework for parathyroid study services and the relationship between technique, date of service, and code changes. It also notes the evolution of coding from earlier approaches to current practice.

5. Coding Tip

   General reminder about documentation expectations when an unlisted procedure code is used. The section focuses on administrative support for claims rather than clinical detail.